home / stock / gwph / gwph news


GWPH News and Press, GW Pharmaceuticals Plc From 04/03/20

Stock Information

Company Name: GW Pharmaceuticals Plc
Stock Symbol: GWPH
Market: NASDAQ
Website: gwpharm.com

Menu

GWPH GWPH Quote GWPH Short GWPH News GWPH Articles GWPH Message Board
Get GWPH Alerts

News, Short Squeeze, Breakout and More Instantly...

GWPH - Innovation In Pharmaceutical And CBD Sales During Coronavirus Shut Down Is Effective Strat-egy

Virtual meetings and digital presentations are one way for pharmaceutical companies to continue to sell retailers during the coronavirus shelter-at-home edicts. This is the strategy for Bayer (NYSE: BAYRY) , Pfizer (NYSE: PFE) , Merck (NYSE: MRK ), GlaxoSmithKline (NYSE: GSK ) and ...

GWPH - More States Issue Stay-At-Home Orders Due To Coronavirus, But Some Rule CBD Dispensa-ries Essential And Let Them Stay Open

Four more states issued coronavirus-related stay-at-home orders Wednesday, including Florida, Nevada, Mississippi and Pennsylvania. CBD licensed dispensaries have been ruled essential businesses and will remain open in Florida and Nevada. In the rest of the nation, states and counties have pro...

GWPH - CBD Sales Spike Prior To Shelter-In-Place Orders, But Its Staying Power Now Is Not As A Coronavirus Cure But As A Reducer Of Anxiety And Stress

More states, such as Florida, issued coronavirus related stay-at-home orders yesterday (April 1, 2020). CBD is not a cure for COVID-19, but it offers relief from anxiety and stress by people who fear they, family or friends may contract it. As a result, we have seen CBD products show staying...

GWPH - CBD Unlimited, Inc.'s Todd Davis, CEO, Reads The CBD Market As A Mass Market

Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC ), illustrates a case in point why the CBD market is changing quick with the mass market playing an important role. Where his company was selling mom-and-pop retailers last year, he’s placed his CBD product on more t...

GWPH - Analysis: M&A Activity In CBD market Is A Smart Strategy To Grow Market Sales, Market Cap

Analysts see the active M&A activity in the CBD market as a great strategy of growing market sales and extending market cap. As the market matures and grows, larger firms will benefit from the consolidation. For example, the move by Charlotte’s Web (NASDAQ: CWBHF) , marketer of h...

GWPH - CBD Unlimited, Inc.'s Todd Davis, CEO, In Update NASDAQ MarketSite Interview Dis-cusses 2nd Quarter

Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC ), in an update interview with NASDAQ MarketSite reporter Jane King discussed the company’s performance in the 2nd Quarter. Conducted at a remote location, the full interview will be available on April 6, 2020. Davis...

GWPH - CBD Dispensaries Ruled Essential And Remain Open In Several States During Coronavirus Outbreak

CBD licensed dispensaries, filling refills of patients, have been ruled essential businesses that  remain open in California, Nevada, Michigan and Illinois. CBD is available to residents of these states during the coronavirus crisis. Online sales of CBD, always a dominant percentage of th...

GWPH - Colgate Palmolive Enters CBD Market By Buying Maker Of CBD-Infused Oral Hygiene Products

The CBD industry’s red-hot M&A activity within the past two months has seen several companies acquired, but none is more intriguing than the move by mainstream firm Colgate Palmolive (NYSE: CL) to acquire Hello Products and its line of oral hygiene products — CBD-infused ...

GWPH - FDA accepts GW Pharma application for expanded use of Epidiolex

Under Priority Review status, the FDA accepts for review GW Pharmaceuticals' (NASDAQ: GWPH ) supplemental marketing application seeking approval to use Epidiolex (cannabidiol) to treat seizures associated with tuberous sclerosis complex , a rare inherited disorder in which non-cancerous t...

GWPH - GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex

CARLSBAD, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc., today announced that the U.S. Fo...

Previous 10 Next 10